Senior insider sale
Chief Business Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.23M
138.38K shares
What this filing means
CHAKMA JUSTIN plans to sell 138.38K shares of ARS PHARMACEUTICALS, INC. valued at approximately $1.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2025ACC: 0001959173-25-006931
Officer· Chief Business Officer
Since Nov 2022
138.38K
Shares to sell
$1.23M
Approx. market value
136.38K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Options Exercise
Compensation
8/11/2021
18.19KStock Options Exercise
Compensation
6/1/2020
118.19KTotal acquired136.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2021 | Stock Options Exercise Compensation | 18.19K | — |
6/1/2020 | Stock Options Exercise Compensation | 118.19K | — |
| Total | 136.38K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
138.38K
Market value
$1.23M
11/12/2025
Total
Units
138.38K
Value
$1.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/12/2025 | 138.38K | $1.23M | NASDAQ | Planned |
| Total | 138.38K | $1.23M | ||